Evaluation of and recommendation for the nomenclature of the CPB2 gene product (also known as TAFI and proCPU): communication from the SSC of the ISTH.

Foley, J H; Kim, P Y; Hendriks, D; Morser, J; Gils, A; Mutch, N J

Foley, J H; Kim, P Y; Hendriks, D; Morser, J; Gils, A; Mutch, N J.

Afiliación

Foley JH; Research Department of Haematology, University College London and Katherine Dormandy Haemophilia Centre and Thrombosis Unit, London, UK.
Kim PY; Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, ON, Canada.
Hendriks D; Laboratory for Medical Biochemistry, University of Antwerp, Antwerp, Belgium.
Morser J; Division of Hematology, School of Medicine, Stanford University, Stanford, CA, USA.
Gils A; Laboratory for Therapeutic and Diagnostic Antibodies, KU Leuven, Leuven, Belgium.
Mutch NJ; Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK.

J Thromb Haemost ; 13(12): 2277-8, 2015 Dec.

Article en En | MEDLINE | ID: mdl-27028102

Asunto(s)

Carboxipeptidasa B2/clasificación; Terminología como Asunto; Carboxipeptidasa B2/genética; Carboxipeptidasa B2/metabolismo; Consenso; Fibrinólisis; Humanos; Medical Subject Headings

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carboxipeptidasa B2 / Terminología como Asunto Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: J Thromb Haemost Asunto de la revista: HEMATOLOGIA Año: 2015 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google